161 related articles for article (PubMed ID: 34471044)
1. Hospital Pharmacometrics for Optimal Individual Administration of Antimicrobial Agents for Anti-methicillin-resistant Staphylococcus aureus Infected Patients.
Tsuji Y
Biol Pharm Bull; 2021; 44(9):1174-1183. PubMed ID: 34471044
[TBL] [Abstract][Full Text] [Related]
2. Optimization of dosing regimens of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant
Wei X; Zhao M; Xiao X
J Chemother; 2021 Dec; 33(8):547-553. PubMed ID: 34080519
[TBL] [Abstract][Full Text] [Related]
3. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
Lim HS; Chong YP; Noh YH; Jung JA; Kim YS
J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of a simulated single 1,200-milligram dose of oritavancin in an in vitro pharmacokinetic/pharmacodynamic model of methicillin-resistant staphylococcus aureus infection.
Belley A; Arhin FF; Sarmiento I; Deng H; Rose W; Moeck G
Antimicrob Agents Chemother; 2013 Jan; 57(1):205-11. PubMed ID: 23089749
[TBL] [Abstract][Full Text] [Related]
5. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate.
Frymoyer A; Hersh AL; Benet LZ; Guglielmo BJ
Pediatr Infect Dis J; 2009 May; 28(5):398-402. PubMed ID: 19295465
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic and pharmacodynamic analyses of teicoplanin in Japanese patients with systemic MRSA infection.
Ogawa R; Kobayashi S; Sasaki Y; Makimura M; Echizen H
Int J Clin Pharmacol Ther; 2013 May; 51(5):357-66. PubMed ID: 23458228
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG
Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677
[TBL] [Abstract][Full Text] [Related]
8. Anti-infective Dosing for Obese Adult Patients: A Focus on Newer Drugs to Treat Methicillin-resistant Staphylococcus aureus Acute Bacterial Skin and Skin Structure Infections.
Pai MP
Clin Ther; 2016 Sep; 38(9):2032-44. PubMed ID: 27524636
[TBL] [Abstract][Full Text] [Related]
9. [A multicentric study on clinical characteristics and antibiotic sensitivity in children with methicillin-resistant
Wu X; Yu H; He LY; Wang CQ; Xu HM; Zhao RQ; Jing CM; Chen YH; Chen J; Deng JK; Shi J; Lin AW; Li L; Deng HL; Cai HJ; Chen YP; Wen ZW; Yang JH; Zhang T; Xiao FF; Cao Q; Huang WC; Hao JH; Zhang CH; Huang YY; Ji XF
Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):628-634. PubMed ID: 32842382
[No Abstract] [Full Text] [Related]
10. Antimicrobial prescribing for treatment of serious infections caused by Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in pediatrics: an expert review.
Avedissian SN; Rhodes NJ; Shaffer CL; Tran L; Bradley JS; Le J
Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1107-1116. PubMed ID: 33554692
[No Abstract] [Full Text] [Related]
11. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
12. Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.
Fukumori S; Tsuji Y; Mizoguchi A; Kasai H; Ishibashi T; Iwamura N; To H
J Clin Pharm Ther; 2016 Aug; 41(4):399-402. PubMed ID: 27144370
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic/Pharmacodynamic Analysis of Daptomycin Against Staphylococcus aureus and Enterococcus faecium in Pediatric Patients by Monte Carlo Simulation.
Wei XC; Zhao MF; Li X; Xiao X
J Clin Pharmacol; 2020 Jun; 60(6):768-774. PubMed ID: 32080861
[TBL] [Abstract][Full Text] [Related]
14. [Antimicrobial resistance of methicillin-resistant Staphylococcus aureus in hospital environment and inpatients].
Wu AH; Li CH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Oct; 30(5):525-30. PubMed ID: 19024378
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study].
Çıkman A; Aydın M; Gülhan B; Parlak M; Gültepe B; Kalaycı Y; Bayındır Bilmen F; Solmaz S; Özekinci T
Mikrobiyol Bul; 2015 Apr; 49(2):240-8. PubMed ID: 26167824
[TBL] [Abstract][Full Text] [Related]
16. Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections.
Giuliano C; Haase KK; Hall R
Expert Rev Anti Infect Ther; 2010 Jan; 8(1):95-106. PubMed ID: 20014904
[TBL] [Abstract][Full Text] [Related]
17. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey].
Cesur S; Irmak H; Simşek H; Cöplü N; Kılıç H; Arslan U; Bayramoğlu G; Baysan BO; Gülay Z; Hoşoğlu S; Berktaş M; Gencer S; Demiröz AP; Esen B; Karabiber N; Aydın F; Yalçın AN
Mikrobiyol Bul; 2012 Jul; 46(3):352-8. PubMed ID: 22951647
[TBL] [Abstract][Full Text] [Related]
19. In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection model.
Louie A; Liu W; Kulawy R; Drusano GL
Antimicrob Agents Chemother; 2011 Jul; 55(7):3453-60. PubMed ID: 21502615
[TBL] [Abstract][Full Text] [Related]
20. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Mogle BT; Steele JM; Seabury RW; Dang UJ; Kufel WD
Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
